ENIGMA and global neuroscience : a decade of large-scale studies of the brain in health and disease across more than 40 countries

dc.contributor.authorThompson, Paul M.en_ZA
dc.contributor.authorJahanshad, Nedaen_ZA
dc.contributor.authorChing, Christopher R. K.en_ZA
dc.contributor.authorSalminen, Lauren E.en_ZA
dc.contributor.authorThomopoulos, Sophia I.en_ZA
dc.contributor.authorBright, Joannaen_ZA
dc.date.accessioned2022-04-06T08:15:37Z
dc.date.available2022-04-06T08:15:37Z
dc.date.issued2020-03-20
dc.descriptionCITATION: Thompson, Paul M. et al. 2020. ENIGMA and global neuroscience : a decade of large-scale studies of the brain in health and disease across more than 40 countries. Translational Psychiatry, 10:100, doi:10.1038/s41398-020-0705-1.en_ZA
dc.descriptionThe original publication is available at: https://www.nature.com
dc.description.abstractThis review summarizes the last decade of work by the ENIGMA (Enhancing NeuroImaging Genetics through MetaAnalysis) Consortium, a global alliance of over 1400 scientists across 43 countries, studying the human brain in health and disease. Building on large-scale genetic studies that discovered the first robustly replicated genetic loci associated with brain metrics, ENIGMA has diversified into over 50 working groups (WGs), pooling worldwide data and expertise to answer fundamental questions in neuroscience, psychiatry, neurology, and genetics. Most ENIGMA WGs focus on specific psychiatric and neurological conditions, other WGs study normal variation due to sex and gender differences, or development and aging; still other WGs develop methodological pipelines and tools to facilitate harmonized analyses of “big data” (i.e., genetic and epigenetic data, multimodal MRI, and electroencephalography data). These international efforts have yielded the largest neuroimaging studies to date in schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorder, substance use disorders, obsessive-compulsive disorder, attentiondeficit/ hyperactivity disorder, autism spectrum disorders, epilepsy, and 22q11.2 deletion syndrome. More recent ENIGMA WGs have formed to study anxiety disorders, suicidal thoughts and behavior, sleep and insomnia, eating disorders, irritability, brain injury, antisocial personality and conduct disorder, and dissociative identity disorder. Here, we summarize the first decade of ENIGMA’s activities and ongoing projects, and describe the successes and challenges encountered along the way. We highlight the advantages of collaborative large-scale coordinated data analyses for testing reproducibility and robustness of findings, offering the opportunity to identify brain systems involved in clinical syndromes across diverse samples and associated genetic, environmental, demographic, cognitive, and psychosocial factors.en_ZA
dc.description.versionPublisher's version
dc.format.extent28 pages : illustrations
dc.identifier.citationThompson, Paul M. et al. 2020. ENIGMA and global neuroscience : a decade of large-scale studies of the brain in health and disease across more than 40 countries. Translational Psychiatry, 10:100, doi:10.1038/s41398-020-0705-1
dc.identifier.issn2158-3188 (online)
dc.identifier.otherdoi:10.1038/s41398-020-0705-1
dc.identifier.urihttp://hdl.handle.net/10019.1/124419
dc.language.isoen_ZAen_ZA
dc.publisherSpringer Nature
dc.rights.holderAuthors retain copyright
dc.subjectBrain -- Diseasesen_ZA
dc.subjectNeurological disordersen_ZA
dc.subjectNervous system -- Diseasesen_ZA
dc.titleENIGMA and global neuroscience : a decade of large-scale studies of the brain in health and disease across more than 40 countriesen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
thompson_enigma_2020.pdf
Size:
2.56 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: